SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,853,522 | -12.3% | 527,382 | +100.4% | 0.00% | -33.3% |
| Q2 2023 | $12,374,018 | -33.7% | 263,165 | -40.8% | 0.00% | -25.0% |
| Q1 2023 | $18,653,276 | +172.4% | 444,549 | +147.6% | 0.00% | +100.0% |
| Q4 2022 | $6,847,846 | -28.3% | 179,545 | -26.4% | 0.00% | -33.3% |
| Q3 2022 | $9,547,000 | +26.7% | 243,787 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $7,534,000 | -48.3% | 233,238 | -47.0% | 0.00% | +50.0% |
| Q1 2022 | $14,568,000 | -63.9% | 440,099 | -53.6% | 0.00% | +100.0% |
| Q4 2021 | $40,322,000 | +103.0% | 947,804 | +111.4% | 0.00% | -50.0% |
| Q3 2021 | $19,863,000 | -26.3% | 448,272 | -5.5% | 0.00% | -33.3% |
| Q2 2021 | $26,956,000 | +15.0% | 474,494 | +51.5% | 0.00% | 0.0% |
| Q1 2021 | $23,441,000 | -68.8% | 313,169 | -64.0% | 0.00% | -50.0% |
| Q4 2020 | $75,204,000 | +198.7% | 869,320 | +111.0% | 0.01% | +20.0% |
| Q3 2020 | $25,180,000 | +37.7% | 411,974 | -6.3% | 0.01% | 0.0% |
| Q2 2020 | $18,287,000 | +34.5% | 439,813 | -7.1% | 0.01% | +25.0% |
| Q1 2020 | $13,592,000 | -81.0% | 473,239 | -52.3% | 0.00% | -81.0% |
| Q4 2019 | $71,658,000 | +9.0% | 992,633 | +111.9% | 0.02% | -4.5% |
| Q3 2019 | $65,712,000 | -73.3% | 468,396 | -65.2% | 0.02% | -29.0% |
| Q2 2019 | $246,245,000 | +289.5% | 1,344,947 | +238.4% | 0.03% | +19.2% |
| Q1 2019 | $63,222,000 | +5.1% | 397,500 | -36.7% | 0.03% | +13.0% |
| Q4 2018 | $60,176,000 | -5.8% | 628,201 | +38.8% | 0.02% | +9.5% |
| Q3 2018 | $63,910,000 | -23.2% | 452,452 | -14.9% | 0.02% | -27.6% |
| Q2 2018 | $83,224,000 | +53.3% | 531,681 | +57.7% | 0.03% | +52.6% |
| Q1 2018 | $54,287,000 | -61.9% | 337,043 | -61.0% | 0.02% | -62.0% |
| Q4 2017 | $142,518,000 | +181.6% | 865,268 | +6.5% | 0.05% | +163.2% |
| Q3 2017 | $50,619,000 | +55.4% | 812,500 | +98.7% | 0.02% | +26.7% |
| Q2 2017 | $32,567,000 | -48.4% | 408,932 | -54.0% | 0.02% | -53.1% |
| Q1 2017 | $63,167,000 | +433.7% | 888,800 | +283.4% | 0.03% | +433.3% |
| Q4 2016 | $11,836,000 | -24.9% | 231,800 | -32.3% | 0.01% | -14.3% |
| Q3 2016 | $15,767,000 | +120.2% | 342,400 | +44.1% | 0.01% | +75.0% |
| Q2 2016 | $7,160,000 | +139.8% | 237,645 | +155.1% | 0.00% | +300.0% |
| Q1 2016 | $2,986,000 | +20.8% | 93,163 | +119.7% | 0.00% | -50.0% |
| Q4 2015 | $2,472,000 | -57.0% | 42,400 | -68.8% | 0.00% | -33.3% |
| Q3 2015 | $5,750,000 | -48.2% | 135,873 | -10.7% | 0.00% | -40.0% |
| Q2 2015 | $11,102,000 | – | 152,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |